Drugs / Eutectic Mixture of Local Anesthetics
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06223659 | Dec 2023 → Oct 2026 expected | cutaneous melanoma, cutaneous neuroendocrine carcinoma, skin squamous cell carcinoma | Ohio State University Comprehensive Cancer Center | Recruiting | No outcome recorded |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT06242977 | Jan → Aug 2024 | hematocele of tunica vaginalis testis, hydrocele, scrotal disorder, spermatocele | University of Manitoba | Unknown | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Eutectic Mixture of Local Anesthetics | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06223659 ↗ |
| Route | Topical | “Apply topically to skin” NCT06223659 ↗ |